Potentiation of natriuretic peptide action by the β-adrenergic blocker carvedilol in hypertensive rats: A new antihypertensive mechanism

Endocrinology

Volumn 139, Issue 1, 1998, Pages 81-88

  Yoshimoto, Takanobu ^a   Naruse, Mitsuhide ^a   Tanabe, Akiyo ^a   Naruse, Kiyoko ^a   Seki, Toshirou ^a   Imaki, Toshihiro ^a   Muraki, Takamura ^a   Matsuda, Yuzuru ^a,b   Demura, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011480389     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.139.1.5644     Document Type: Article

References (55)

1. AbboundFM1982The sympathetic system in hypertension. State of the art review.Hypertension4:208-225
2. Guideline Subcommittee 1989Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens7:689-693
3. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure 1988The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med148:1023-1038
4. CruickshankJM, PrichardBNC1994Beta-blockers. In: Swales JD (ed) Textbook of Hypertension. Blackwell, Oxford, pp 1067-1069
5. YusufS, WittesJ, FriedmanL1988Overview of results of rondomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA260:2088-2093
6. PackerM, BristowMR, CohnJN, ColucciWS, FowlerMB, GilbertEM, ShustermanNH1996The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med334:1349-1355
7. RosenzweigA, Seidman CE1991 Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem60:229-255
8. Maack T 1992 Receptors of atrial natriuretic factor. Annu Rev Physiol 54:11-27
9. KnorrA, KazdaS, NeuserD, StaschJP, SeuterF1991Long-term protective effects of nitrendipine in experimental hypertension. J Cardiovasc Pharmacol [Suppl5]18:S1-S4
10. PhillipsRA, ArdeljanM, ShimabukuroS, GoldmanME, GarbowitDL, EisonHB, KrakoffLR1991Normalization or left ventricular mass and associated changes in nifedipine therapy for severe hypertension. J Am Coll Cardiol17:1595-1602
11. CappuccioFP, MarkanduND, SagnellaGA, SingerDR, BuckleyMG1991Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldo-sterone system, atrial natriuretic peptide, and blood pressure in essential hypertension.J Hum Hypertens5:115-119
12. NishimuraH, KubotaJ, OkabeM, UeyamaM, KawamuraK1992Effects of lisinopril upon cardiac hypertrophy, central and peripheral hemodynamics, and neurohumoral factors in spontaneously hypertensive rats. J Hypertens10:431-436
13. StaschJP, Hirth-DietrichC, FrobelK, WegnerM1995Prolonged endothelin blockade prevents hypertension and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Am J Hypertens8:1128-1134
14. NakaokaH, KitaharaY, AmanoM, ImatakaK, FujiiJ, IshibashiM, YamajiT1987Effects of γ-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension. Hypertension10:221-225
15. YamamotoJ, MatsubaraH, NakaiM1989Effects of arotinolol on hemodynamics and plasma atrial natriuretic peptide at rest and during stress in spontaneously hypertensive rats. Clin Exp Hypertens [A]11:1441-1454
16. TonkinAL, WingLMH, RussellAE, WestMJ, BuneAJC, MorrisMJ, CainMD, ChalmersJ1990Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy. J Hypertens8:1015-1019
17. HollenbeckM, PlumJ, HeeringP, KutkuhnB, GrabenseeB1991Influence of betaxolol on renal function and atrial natriuretic peptide in essential hypertension. J Hypertens9:819-824
18. HamaJ, NagataS, TakenakaT, KinoH, KamoiK, ShimadaS, HoriuchiM, KatoriR1995Atrial natriuretic peptide and antihypertensive action due to β-blockade in essential hypertensive patients. Angiology46:511-566
19. TanakaM, MasumuraH, TanakaS, AkashiA1987Studies on the antihypertensive properties of carvedilol, a compound with β-blocking and vasodilating effects. J Cardiovasc Pharmacol [Suppl 11]10:S52-S57
20. MatsudaY, MorishitaY1993HS-142-1: a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. Cardiovasc Drug Rev11:45-59
21. MaackT, SuzukiM, AlmediaFA, NussenzveigD, ScarboroughRM, McEnroeGA, LewickiJA1987Physiological role of silent receptors of atrial natriuretic factor. Science238:675-678
22. NussenzveigDR, LewickiJA, MaackT1990Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor.J Biol Chem265:20952-20958
23. NabikaT, NaraY, IkedaK, EndoJ, YamoriY1991Genetic heterogenity of the spontaneously hypertensive rats between the different sources. Hypertension18:12-16
24. ChomczynskiP, SacchiN1987Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem162:156-159
25. YoshimotoT, NaruseM, NaruseK, ShionoyaK, TanakaM, TanabeA, HagiwaraH, HiroseS, MurakiT, DemuraH1996Angiotensin II-dependent down-regulation of vascular natriuretic peptide receptor gene expression in hypertensive rats. Endocrinology137:1102-1107
26. YoshimotoT, NaruseM, NaruseK, FujimakiY, TanabeA, MurakiT, ItakuraM, HagiwaraH, HiroseS, DemuraH1995Modulation of vascular natriuretic peptide receptor gene expression in hypertensive and obese hyperglycemic rats. Endocrinology136:2427-2434
27. KangawaK, TawaragiY, OikawaS, MizunoA, SakuragawaY, NakazatoH, FukudaA, MinaminoN, MatsuoH1984Identification of rat gamma atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor. Nature312:152-155
28. SchiffrinEL, St-LouisJ1987Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats. Hypertension9:504-512
29. KishimotoI, YoshimasaT, SugaS, OgawaY, KomatsuY, NakagawaO, ItohH, NakaoK1994Natriuretic peptide clearance receptor is transcriptionally down-regulated by fo-adrenergic stimulation in vascular smooth muscle cells. J Biol Chem269:28300-28308
30. YokotaN, YamamotoY, KitamuraK, KangawaK, MinaminoN, MatsuoH, EtoT1993Alteration in circulating and cardiac tissue concentrations of brain natriuretic peptide in spontaneously hypertensive rats. Cardiovasc Res27:1312-1315
31. NaruseM, TakeyamaY, TanabeA, HiroshigeJ, NaruseK, YoshimotoT, TanakaM, KatagiriT, DemuraH1994Atrial and brain natriuretic peptides in cardiovascular diseases. Hypertension [Suppl 1] 23:1231-1234
32. WagnerJG1975The two compartment open model. In: Wagner JG (ed) Fundamentals of Clinical Pharmacokinetics. Hamilton Press., pp 82-83
33. YoshimotoT, NaruseM, NaruseK, AraiK, ImakiT, TanabeA, SekiT, HiroseS, MurakiT, DemuraH1996Vascular action of circulating and local natriuretic peptide systems is potentiated in obese/hyperglycemic and hypertensive rats. Endocrinology137:5552-5557
34. SchiffrinEL, ParentA, St-LouisJ, TremblayJ, GarciaR, ThibaultG1992Vascular atrial natriuretic factor receptors in spontaneously hypertensive rats. Cardiovasc Res26:857-864
35. ZengZP, NaruseM, NaruseK, KatoY, ShiYF, DemuraH, ShizumeK1991Antiserum against homologous atrial natriuretic peptide diminishes the natriuretic response during mineralocorticoid escape in rats. Endocrinology128:226-230
36. HashimotoY, NakaoK, HamaN, MukoyamaM, ImuraH, YasuharaM, Hori R 1992 Pharmacokinetics of brain natriuretic peptide in rats. Chem Pharm Bull40:1650-1652
37. CurrieMG, NewmanWH1986Evidence for α-1 adrenergic receptor regulation of atriopeptine release from the isolated rat heart.Biochem Biophys Res Commun137:94-100
38. WongNL, WongEF, AuGH, HuDC1988Effect of alpha- and beta-adrenergic stimulation on atrial natriuretic peptide release in vitro.Am J Physiol255:E260-E264
39. SugaS, NakaoK, MukoyamaM1990Natriuretic peptide receptor. J Jpn Coll Angiol30:1239-1244
40. KlingerJR, MoalliR, WarburtonRR, WrennDS, HillNS1992C-Receptor ligand blocks pulmonary clearance of atrial natriuretic peptide in isolated rat lung. Proc Soc Exp Biol Med201:154-158
41. HollisterAS, RodehefferRJ, WhiteFJ, PottsJR, ImadaT, InagamiT1989Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest83:623-628
42. PerrellaMA, MarguliesKB, WeiCM, AarhusLL, HeubleinDM, BurnettJrJC1991Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs. J Clin Invest87:1649-1655
43. YoshimotoT, NaruseM, TanabeA, NaruseK, TakagiK, MurakiT, ItakuraM, HagiwaraH, HiroseS, DemuraH1994Angiotensin converting enzyme inhibitor but not calcium blocker down-regulates gene expression of vascular natriuretic peptide receptor in hypertensive rats. Biochem Biophys Res Commun205:1595-1600
44. YoshimotoT, NaruseK, ShionoyaK, TanakaM, SekiT, HagiwaraH, HiroseS, KuenLS, DemuraH, NaruseM, MurakiT1996Angiotensin converting enzyme inhibitor normalizes vascular natriuretic peptide type A receptor gene expression via bradykinin-dependent mechanism in hypertensive rats. Biochem Biophys Res Commun218:50-53
45. HirataY, MatsuokaH, SuzukiE, HayakawaH, SugimotoT, MatsudaY, MorishitaY, KangawaK, MinaminoN, MatsuoH, SugimotoT1993Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats: effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Circulation87:554-561
46. NicholsAJ, GellaiM, RuffoloJrRR1991Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Fund Clin Pharmacol5:25-38
47. KatafuchiT, MizunoT, HagiwaraH, ItakuraM, ItoT, HiroseS1992Modulation by NaCl of atrial natriuretic peptide receptor levels and cyclic GMP responsiveness to atrial natriuretic peptide of cultured vascular endothelial cells. J Biol Chem267:7624-7629
48. ChabrierPE, RoubertP, LonchamptMO, PlasP, BraquetP1988Regulation of atrial natriuretic factor receptors bv angiotensin II in rat vascular smooth muscle cells. J Biol Chem263:13199-13202
49. KatoJ, Lanier-SmithKL, CurrieMG1991Cyclic GMP downregulates atrial natriuretic peptide receptors on cultured vascular endothelial cells.J Biol Chem266:14681-14685
50. KishimotoI, NakaoK, SugaS, HosodaK, YoshimasaT, ItohH, Imura H1993 Downregulation of C-receptor by natriuretic peptides via ANP-B receptor in vascular smooth muscle cells. Am J Physiol265:H1373-H1379
51. FeuersteinGZ, RuffoloRR Jr1996Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. Eur Heart J [Suppl B]17:24-29
52. GuamieriC, GiordanoE, MuscariC, GrossiL, CaldareraCM1996Alpha- tocopherol pretreatment improves endothelium-dependent vasodilation in aortic strips of young and aging rats exposed to oxidative stress. Moll Cell Biochem157:223-228
53. LilleyE, GibsonA1996Antioxidant protection of NO-induced relaxations of the mouse anococcygeus against inhibition by superoxide anions, hydroqui-none and carboxy-PTIO. Br J Pharmacol119:432-438
54. FiferMA, MolinaCR, QuirozAC, GilesTD, HerrmannHC, De ScheerderIR, ClementDL, KuboS, CodyRJ, CohnJN, FowlerMB1990Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. Am J Cardiol65:211-215
55. SaitoY, NakaoK, NishimuraK, SugawaraA, OkumuramK, ObataK, SonodaR, BanT, YasueH, ImuraH1987Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation76:115-124